series-b
Stage
2018
Founded
2
Investors
About
Nuclera is a biotechnology company developing a desktop bioprinter that enables rapid protein prototyping and drug discovery by making protein expression and characterization accessible to researchers.
Explore Nuclera's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.